Immunovant

Financial Planning and Analysis

• Own development and monitoring of annual budgets, quarterly forecasts, and month-end reporting of actual results for Research & Development
• Support the CFO with comprehensive multi-year strategic financial planning, including summaries for the Board of Directors and executive leadership
• Own trial-level clinical cost models and key assumptions for active and planned studies
• Translate changes in clinical plans and scenarios into budget, forecast, and long-range plan impacts
• Lead the R&D quarterly forecast cycle and prepare R&D inputs for forecasts and Board materials
• Partner with Accounting on R&D month-end close, CRO and clinical trial accrual estimates, variance analysis, and timing versus permanent variance assessment
• Partner with Clinical Procurement and Clinical Operations to evaluate CRO and vendor proposals, contracts, and change orders
• Quantify risks and opportunities against forecast and cash flow
• Provide business and financial analysis and decision support for management
• Support preparation for board, shareholder, and executive leadership meetings and strategic initiatives
• Establish timely reports, analytics, and financial reviews for business leaders
• Build and maintain business partnerships to support operational and strategic decision-making
• Provide candid, solutions-oriented counsel to leadership
• Support the CFO with business development and financing projects as needed
• Develop ad hoc analyses and practical models for leadership
• Facilitate integration of business processes, people, and technology to provide useful information and practical business counsel

Explore Director, Financial Planning & Analysis at Immunovant. Review requirements and application details.